Quant Investing Platforms in India: A Fair Roundup

There is no single best quant investing platform in India, because the products in this category are solving visibly different problems. Some are built to construct and execute a rules-based portfolio, some to automate trading, some to screen and analyse, and some to supply the research layer a professional desk works from. This roundup describes the categories fairly, names representative products from their public materials, and gives you a way to decide which one is yours.

What counts as a quant investing platform

The label covers any tool that lets you replace judgement calls with explicit, repeatable rules and then test those rules. In practice, Indian offerings cluster into four groups.

Basket builders with execution. You define rules or pick a curated portfolio, backtest it, and invest through a connected broker. smallcase popularised the format with curated stock and ETF baskets that settle directly into your own demat account, and it also lets you assemble your own. Kalpi approaches the same category from the rules side, with a no-code Basket Builder, template and static baskets, live strategy tracking, and broker execution.

Systematic and algorithmic trading tools. These focus on signal generation and order execution, usually on technical rules and shorter horizons. Streak and Tradetron are the names most commonly cited in India for no-code strategy creation, backtesting and deployment. The design goal here is latency, order handling and automation rather than fundamental depth.

Analytics and screening portals. Screener.in, Tickertape and Trendlyne sit here. They are strong at filtering a universe, comparing companies and reading a market, and several offer some form of historical testing on a screen. They are research aids more than portfolio engines.

Research infrastructure for professionals. This is the layer PMS firms, AIFs, family offices and MFDs work from: fundamental history, point-in-time data, factor libraries, and outputs that survive an investment committee. Kalpi’s separate institutional product KalpiQuant sits in this group, with a pre-computed factor library, a backtesting engine and portfolio optimisation. Altys Labs approaches the same audience from the fundamental research side.

Product details change, so treat the descriptions above as accurate to each company’s public materials at the time of writing and check the current sites before deciding anything.

The axes that actually separate them

Feature lists are long and overlapping. These five questions separate the category far more cleanly.

1. Does it execute? A platform that connects to a broker turns a rule into a holding. One that does not is a research tool, and you will need a broker anyway. Neither is better. They are different scopes.
2. What data does the backtest see? Price-only backtests are the norm and are legitimate for price-based rules. The moment a rule touches earnings, margins or balance-sheet items, the question becomes whether the test uses the numbers as they were reported at the time or as they were later restated.
3. How deep do the fundamentals go? Ratios computed from a standardised database are one level. Filings, earnings-call transcripts, management guidance and shareholding detail are another.
4. Can you trace a number? For a regulated or fiduciary desk, a figure that cannot be traced to a document, a line and a date is difficult to put in a memo.
5. What comes out at the end? A portfolio you can invest in, an order, a screen, or a written research view. That output is usually the truest description of what a platform is for.

Where backtesting quality quietly matters

Every platform in the category shows a backtest. The interesting variation is in what the backtest is honest about. Survivorship, costs, liquidity and overfitting change results far more than most users expect, and a beautiful equity curve tells you nothing about which of those were handled.

If you are evaluating platforms, read their documentation on these points before you read their marketing. Our companion pieces on common backtesting mistakes, survivorship bias in backtests and transaction costs in backtests give you the checklist to apply. The metrics themselves, from CAGR through Sharpe to drawdown, are collected in our portfolio metrics hub.

Which category fits whom

If you are	The fit is usually	Because
A self-directed investor wanting discipline	A basket builder with execution	Rules become a real portfolio without leaving the tool
A systematic trader on shorter horizons	An algo trading platform	Order automation and technical signal handling are the core
An analyst screening and comparing companies	An analytics portal	Fast filtering and comparison, low setup cost
A PMS, AIF, family office or MFD	Research infrastructure	Fundamental depth, point-in-time history, auditable figures, committee-ready output
A team doing all of the above	Two tools, honestly	Very few products span construction, execution and deep research equally well

Where Altys fits

Altys Labs is an equity research and fundamental analysis platform for Indian stocks (NSE and BSE) and Indian mutual funds, built for professional users: PMS firms, AIFs, family offices and MFDs. It is currently invite-only, in private preview. Its focus, stated as focus and not as superiority, is the research layer: India-deep coverage of filings, concall transcripts, management guidance, shareholding, macro series, FII and DII flows, factor scores and fund data; point-in-time history so a test sees what was knowable then; figures linked back to source document, line and date; and screening, modelling, forecasting and backtesting on top. It is not a broker, does not execute, and is not a SEBI-registered research analyst or adviser.

If your bottleneck is getting money into a rules-based portfolio, a basket platform is the right answer and Altys is not trying to be one. If your bottleneck is defending the research underneath the rule, that is the gap it addresses.

A sane way to choose

Write down the last three things that slowed your process. If they were “I could not act on my own screen”, pick for execution. If they were “I could not tell whether the backtest was fooling me”, pick for data honesty and read the documentation on survivorship and costs. If they were “I could not show the committee where the number came from”, pick for traceability. The platform that removes your actual bottleneck beats the one with the longest feature list, every time.

Related reading

• Portfolio metrics explained: the hub for the risk, return and backtest vocabulary these platforms use.
• Kalpi alternatives for deep fundamental research: a closer look at one platform in the category and where the jobs diverge.
• Best backtesting platforms in India: what to check before trusting any backtest engine.
• Rule-based investing platforms compared: the same category compared on the axes that matter.
• Quant investing in India: the state of quant practice here, plainly described.

This article is educational. Altys Labs is not a registered research analyst or investment adviser, and nothing here is investment advice or a recommendation to buy, sell, or hold any security.